Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Popkin, 2012, Global nutrition transition and the pandemic of obesity in developing countries, Nutr Rev, 70, 3, 10.1111/j.1753-4887.2011.00456.x
Everhart, 2009, Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial, Gastroenterology, 137, 549, 10.1053/j.gastro.2009.05.007
Raynard, 2002, Risk factors of fibrosis in alcohol-induced liver disease, Hepatology, 35, 635, 10.1053/jhep.2002.31782
Berzigotti, 2010, Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis, Hepatology, 54, 555, 10.1002/hep.24418
Meza-Junco, 2013, Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma, J Clin Gastroenterol, 47, 861, 10.1097/MCG.0b013e318293a825
Kaido, 2013, Impact of sarcopenia on survival in patients undergoing living donor liver transplantation, American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 13, 1549, 10.1111/ajt.12221
Krell, 2013, Association between sarcopenia and the risk of serious infection among adults undergoing liver transplantation, Liver Transpl, 19, 1396, 10.1002/lt.23752
Englesbe, 2010, Sarcopenia and mortality after liver transplantation, J Am Coll Surg, 211, 271, 10.1016/j.jamcollsurg.2010.03.039
Montano-Loza, 2012, Muscle wasting is associated with mortality in patients with cirrhosis, Clin Gastroenterol Hepatol, 10, 166, 10.1016/j.cgh.2011.08.028
Johnson, 2013, Nutrition assessment and management in advanced liver disease, Nutr Clin Pract, 28, 15, 10.1177/0884533612469027
O'Brien, 2008, Nutrition in end-stage liver disease: principles and practice, Gastroenterology, 134, 1729, 10.1053/j.gastro.2008.02.001
Montano-Loza, 2013, New concepts in liver cirrhosis: clinical significance of sarcopenia in cirrhotic patients, Minerva Gastroenterol Dietol, 59, 173
Montano-Loza, 2014, Muscle wasting: a nutritional criterion to prioritize patients for liver transplantation, Curr Opin Clin Nutr Metab Care, 17, 219, 10.1097/MCO.0000000000000046
Masuda, 2014, Sarcopenia is a prognostic factor in living donor liver transplantation, Liver Transplant, 20, 401, 10.1002/lt.23811
Tsien, 2013, Reversal of sarcopenia predicts survival after a transjugular intrahepatic portosystemic stent, Eur J Gastroen Hepat, 25, 85, 10.1097/MEG.0b013e328359a759
Durand, 2014, Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography, J Hepatol, 60, 1151, 10.1016/j.jhep.2014.02.026
Mourtzakis, 2008, A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care, Appl Physiol Nutr Metab, 33, 997, 10.1139/H08-075
Dasarathy, 2012, Consilience in sarcopenia of cirrhosis, J Cachexia Sarcopenia Muscle, 3, 225, 10.1007/s13539-012-0069-3
Lang, 2009, Frailty syndrome: a transitional state in a dynamic process, Gerontology, 55, 539, 10.1159/000211949
Baumgartner, 1998, Epidemiology of sarcopenia among the elderly in New Mexico, Am J Epidemiol, 147, 755, 10.1093/oxfordjournals.aje.a009520
Lang, 2010, Sarcopenia: etiology, clinical consequences, intervention, and assessment, Osteoporos Int, 21, 543, 10.1007/s00198-009-1059-y
Schrager, 2007, Sarcopenic obesity and inflammation in the InCHIANTI study, J Appl Physiol, 102, 919, 10.1152/japplphysiol.00627.2006
Kim, 2013, Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean Sarcopenic Obesity Study, Clin Endocrinol (Oxf), 78, 525, 10.1111/j.1365-2265.2012.04433.x
Gallagher, 2005, Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue, Am J Clin Nutr, 81, 903, 10.1093/ajcn/81.4.903
Petersen, 2003, Mitochondrial dysfunction in the elderly: possible role in insulin resistance, Science, 300, 1140, 10.1126/science.1082889
Visser, 2005, Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons, J Gerontol A Biol Sci Med Sci, 60, 324, 10.1093/gerona/60.3.324
Mitsiopoulos, 1998, Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography, J Appl Physiol, 85, 115, 10.1152/jappl.1998.85.1.115
Kvist, 1986, Adipose tissue volume determinations in women by computed tomography: technical considerations, Int J Obes, 10, 53
Vehmas, 1996, Measuring visceral adipose tissue content from contrast enhanced computed tomography, Int J Obes Relat Metab Disord, 20, 570
Martin, 2013, Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index, J Clin Oncol, 31, 1539, 10.1200/JCO.2012.45.2722
Vaughan, 2013, Cancer cachexia: impact, mechanisms and emerging treatments, J Cachexia Sarcopenia Muscle, 4, 95, 10.1007/s13539-012-0087-1
Merli, 2010, Cirrhotic patients are at risk for health care-associated bacterial infections, Clin Gastroenterol Hepatol, 8, 979, 10.1016/j.cgh.2010.06.024
Owen, 1981, Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis, J Clin Invest, 68, 240, 10.1172/JCI110240
Kondrup, 1992, Nutritional therapy in patients with liver cirrhosis, Eur J Clin Nutr, 46, 239
Beyer, 2012, Chronic low-grade inflammation and age-related sarcopenia, Curr Opin Clin Nutr Metab Care, 15, 12, 10.1097/MCO.0b013e32834dd297
Dasarathy, 2011, Sarcopenia associated with portosystemic shunting is reversed by follistatin, J Hepatol, 54, 915, 10.1016/j.jhep.2010.08.032
Taylor, 2001, Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells, Am J Physiol Endocrinol Metab, 280, E221, 10.1152/ajpendo.2001.280.2.E221
Qiu, 2012, Hyperammonemia-mediated autophagy in skeletal muscle contributes to sarcopenia of cirrhosis, Am J Physiol Endocrinol Metab, 303, E983, 10.1152/ajpendo.00183.2012
Montano-Loza, 2013, New cutoff values for sarcopenia for predicting 6-months mortality in cirrhotic patients, J Hepatol, 58, S95, 10.1016/S0168-8278(13)60223-8